Supplement

See all supplements

Multiple Myeloma

Vol. 480 No. 7377_supp ppS33-S80
  • In this Supplement

  • Despite a rash of new drugs and advances in stem-cell therapy, this rare, bloodborne cancer is still an almost certain death sentence. Although a cure remains a long way off, studies of multiple myeloma are yielding insights into bone biology, the role of the tumour microenvironment and the origins of a whole range of different cancers.

    Cover Art: Matthew Hollister

Outlook

Top

Collection

Top
  • Initial genome sequencing and analysis of multiple myeloma

    • Michael A. Chapman
    • Michael S. Lawrence
    • Jonathan J. Keats
    • Kristian Cibulskis
    • Carrie Sougnez
    • Anna C. Schinzel
    • Christina L. Harview
    • Jean-Philippe Brunet
    • Gregory J. Ahmann
    • Mazhar Adli
    • Kenneth C. Anderson
    • Kristin G. Ardlie
    • Daniel Auclair
    • Angela Baker
    • P. Leif Bergsagel
    • Bradley E. Bernstein
    • Yotam Drier
    • Rafael Fonseca
    • Stacey B. Gabriel
    • Craig C. Hofmeister
    • Sundar Jagannath
    • Andrzej J. Jakubowiak
    • Amrita Krishnan
    • Joan Levy
    • Ted Liefeld
    • Sagar Lonial
    • Scott Mahan
    • Bunmi Mfuko
    • Stefano Monti
    • Louise M. Perkins
    • Robb Onofrio
    • Trevor J. Pugh
    • S. Vincent Rajkumar
    • Alex H. Ramos
    • David S. Siegel
    • Andrey Sivachenko
    • A. Keith Stewart
    • Suzanne Trudel
    • Ravi Vij
    • Douglas Voet
    • Wendy Winckler
    • Todd Zimmerman
    • John Carpten
    • Jeff Trent
    • William C. Hahn
    • Levi A. Garraway
    • Matthew Meyerson
    • Eric S. Lander
    • Gad Getz1
    • Todd R. Golub

    Nature471, 467-472 ()